JORDAN GARRY: Open Payments
NPI 1417470857 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Calliditas Therapeutics US Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $43 |
| SCPHARMACEUTICALS INC. | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $21 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: JARDIANCE, Kerendia, TARPEYO, FUROSCIX, ACTHAR, VELPHORO, Veltassa, TAVNEOS.
Industry payments across NE — which companies pay providers there.
